The University of Iowa Clinical and Translational Science Award
爱荷华大学临床和转化科学奖
基本信息
- 批准号:10158985
- 负责人:
- 金额:$ 15.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:AcademyAdministrative SupplementAffectAgeAnimalsAttentionAutomobile DrivingBudgetsClinicClinicalClinical ResearchClinical SciencesClinical TrialsClinical and Translational Science AwardsCollaborationsCommunicationCommunity PracticeComputer softwareComputerized Medical RecordControl GroupsDataDevelopmentDisciplineE-learningEducational process of instructingEnrollmentEnsureEvaluationFamily PhysiciansFundingGeographyGleanGoalsGrantHealthHealthcareHome environmentHumanHuman Subject ResearchIndustryInstitutesInstructionIowaKnowledgeLeadLearningLifeMedical Care TeamMethodsOutcomePatient ParticipationPerformancePharmacistsPilot ProjectsPositioning AttributePostdoctoral FellowProcessPublicationsQuality ControlRegulationReportingResearchResearch PersonnelResearch TrainingRoleRuralRural PopulationSchool NursingSeriesSpecialistSystemTestingTimeTrainingTranslational ResearchTranslationsUniversitiesUpdatecatalystcommunity organizationsdesignefficacy testingevidence baseexperiencehuman subjectimprovedinformatics infrastructureinnovationlecturesmeetingsnovelnovel strategiesprogramsquality assuranceruralitysuccesstooltranslational scientistvirtual
项目摘要
ABSTRACT
The Institute for Clinical and Translational Science (ICTS) at the University of Iowa (UI) was established by the
Board of Regents to realize three objectives – first, to lead the development of translational science at the UI;
second, to advance translational science as a distinct academic discipline; and third, to disseminate capacities
in translational science across the State of Iowa. This mandate enabled us to tackle large problems affecting
translational science that required institutional solutions, such as transforming regulatory processes for human
subjects research, developing an informatics infrastructure for integrating electronic medical record and other
health care data, establishing bi-directional relationships with community organizations, and revitalizing the
pipeline of well trained clinical and translational researchers.
Iowa is a rural state, which brings special health care needs and challenges. We have used these rural
considerations as a catalyst for driving our approach to clinical and translational research pushing our teams to
develop strategies to engage rural populations of all ages and backgrounds and to create new approaches that
overcome the geographic barriers in a rural state. We are capitalizing on our established community practice
networks of family physicians, clinics, school nurses and pharmacists. We utilize e Health/ e Learning
platforms in novel ways and will test the efficacy of these new methods of engagement. As we move research
“Beyond Our Borders,” we have created methods to capture real-time, real-life data from the home and to
correlate this environmentally specific, comprehensive data to human performance. The ICTS is engaging with
other CTSA hubs and national CTR systems to empirically test different approaches and to develop the
evidence base of proven strategies for accelerating translation that can be more broadly disseminated. Though
distance and rurality drive our approaches, the strategies that we develop are simply new and potentially better
ways to generate broad representation and improved participation by patients, healthcare teams and
academicians. Through our local, state and national partnerships, UI and the ICTS are poised to move clinical
and translational discovery rapidly into healthcare practice in a variety of clinical settings.
抽象的
爱荷华大学(UI)的临床与转化科学研究所(ICT)是由
董事会实现三个目标 - 首先是领导UI转化科学的发展;
其次,将转化科学作为一门独特的学科发展;第三,传播能力
爱荷华州的翻译科学。这项任务使我们能够解决影响影响的大问题
需要机构解决方案的转化科学,例如改变人类的监管过程
受试者研究,开发一个信息基础设施,用于整合电子病历和其他
医疗保健数据,与社区组织建立双向关系,并振兴
训练有素的临床和翻译研究人员的管道。
爱荷华州是一个农村国家,带来了特殊的医疗保健需求和挑战。我们使用了这些乡村
考虑因素是推动我们进行临床和翻译研究方法的催化剂,将我们的团队推向
制定策略来吸引各个年龄段和背景的农村人口,并创建新方法
在粗糙状态下克服地理障碍。我们正在利用我们既定的社区实践
家庭医生,诊所,学校护士和药剂师的网络。我们利用E健康/ E学习
以新颖的方式平台,并将测试这些新参与方法的效率。随着我们的研究
“超越我们的边界”,我们创建了从家中捕获实时,现实生活数据的方法
将此具有环境,全面的数据与人类绩效相关联。信息通信技术正在与
其他CTSA枢纽和国家CTR系统,以经验测试不同的方法并开发
可以更广泛传播的加速翻译策略的证据基础。尽管
距离和粗糙度推动了我们的方法,我们制定的策略只是新的,并且可能更好
产生广泛代表和改善患者,医疗团队和改善参与的方法
院士。通过我们的本地,州和国家合作伙伴关系,UI和ICT被中毒以移动临床
并在各种临床环境中迅速转化为医疗保健实践。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patricia Winokur其他文献
Patricia Winokur的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patricia Winokur', 18)}}的其他基金
Vaccine and Treatment Evaluation Unit: Phase I Trial of a Yellow Fever Virus Vaccine
疫苗和治疗评估单位:黄热病病毒疫苗的一期试验
- 批准号:
9430337 - 财政年份:2015
- 资助金额:
$ 15.36万 - 项目类别:
Phase I Trial of Yellow Fever Virus Vaccines - VTEU
黄热病病毒疫苗一期试验 - VTEU
- 批准号:
9161831 - 财政年份:2015
- 资助金额:
$ 15.36万 - 项目类别:
The University of Iowa Clinical and Translational Science Award
爱荷华大学临床和转化科学奖
- 批准号:
9127390 - 财政年份:2015
- 资助金额:
$ 15.36万 - 项目类别:
Phase I Trial of Yellow Fever Virus Vaccines - VTEU
黄热病病毒疫苗一期试验 - VTEU
- 批准号:
9275283 - 财政年份:2015
- 资助金额:
$ 15.36万 - 项目类别:
Phase I Trial of Tuberculosis Vaccine - VTEU
结核疫苗 I 期试验 - VTEU
- 批准号:
9116057 - 财政年份:2014
- 资助金额:
$ 15.36万 - 项目类别:
Phase I Trial of Tuberculosis Vaccine - VTEU
结核疫苗 I 期试验 - VTEU
- 批准号:
8947766 - 财政年份:2014
- 资助金额:
$ 15.36万 - 项目类别:
相似海外基金
Secondary Analysis and Integration of Existing Data Related to Chronic Orofacial Pain and Placebo Effects - Administrative Supplement
与慢性口面部疼痛和安慰剂效应相关的现有数据的二次分析和整合 - 行政补充
- 批准号:
10741330 - 财政年份:2023
- 资助金额:
$ 15.36万 - 项目类别:
CommuniTy Partnerships tO EnGagE UnderrepresenTed Persons witH AlzhEimer's Disease in Dysphagia Research (TOGETHER)
社区伙伴关系让代表性不足的阿尔茨海默病患者(共同)参与吞咽困难研究
- 批准号:
10841340 - 财政年份:2020
- 资助金额:
$ 15.36万 - 项目类别:
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS)
MACS/WIHS 联合队列研究 (MACS/WIHS-CCS) 的临床研究中心
- 批准号:
10401178 - 财政年份:2019
- 资助金额:
$ 15.36万 - 项目类别:
Development of Flow Based Biomarkers for Retinopathy of Prematurity - Supplemental Aim
基于流的早产儿视网膜病变生物标志物的开发 - 补充目标
- 批准号:
10098795 - 财政年份:2019
- 资助金额:
$ 15.36万 - 项目类别:
Addition of Social Needs to a Telephone-Based Developmental Care Coordination Randomized Controlled Trial in the Era of COVID
在新冠病毒时代,将社会需求添加到基于电话的发育护理协调随机对照试验中
- 批准号:
10242405 - 财政年份:2018
- 资助金额:
$ 15.36万 - 项目类别: